ylliX - Online Advertising Network
Video News

Evidence to approve of Biogen’s Alzheimer’s drug was not ‘sufficient,’ says Penn’s Dr. Jason Karlawi

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Dr. Jason Karlawish, co-director of the University of Pennsylvania Medical Center, joins ‘The News with Shepard Smith’ to discuss the new Alzheimer’s drug, saying that the evidence to approve the drug “was not sufficient.”

...read full article on CNBC Television

ylliX - Online Advertising Network